Related to this topic: Support | Weblinks | Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Lowe (Oculo-Cerebro-Renal) Syndrome

Synonyms: oculo-cerebro-renal syndrome, OCRL, Lowe-Terrey-MacLachlan syndrome and 4,5-bisphosphate 5-phosphatase deficiency.

This is an X-linked condition due to a mutation on the Xq26.1 gene.1 The mutation of the OCRL1 gene also causes Dent's disease.
The classical diagnostic triad includes:

  • Congenital cataracts
  • Neonatal or infantile hypotonia with subsequent mental impairment
  • Renal tubular dysfunction progressing to chronic renal failure
Epidemiology

It is a rare condition that usually affects just males with female carriers. There are 3 recorded cases of the disease affecting females. This might be due to mutation on an autosome rather than the X chromosome or it may represent "infelicitous lyonization in heterozygous females". This relates to the Lyon hypothesis that in females, one of the X chromosomes is suppressed.

The incidence is about 1 in 500,000.2

Presentation

The syndrome was first described by Lowe, Terrey and MacLachlan in 1952.3 The cardinal features are:

  • Hydrophthalmia (congenital glaucoma), cataract, mental retardation, vitamin D-resistant rickets, amino aciduria, and reduced ammonia production by the kidney. Glaucoma occurs in about half but cataracts are almost invariably present at birth.
  • Hyporeflexia and hypotonia are usual features. 'Ragged red fibre' muscle pathology has been described
  • Linear growth decreases after 1 year of age and bone age lies between the chronologic age and height age.4
  • Renal dysfunction, is characterized by proteinuria, generalized amino aciduria, carnitine wasting, and phosphaturia in the first year of life. Renal function is normal at birth but is abnormal by the first birthday. Urinary wasting of individual amino acids is milder than in cystinosis. Serum creatinine levels rise with age, heralding inevitable chronic renal failure.4
  • In the blood, concentrations of the muscle enzymes creatine kinase, aspartate aminotransferase, and lactate dehydrogenase are elevated, as well as of total plasma protein, alpha-2-globulin, and high-density lipoprotein cholesterol. Most patients require alkalinisation therapy and many benefit from supplemental potassium, phosphate, calcium, and carnitine. The serum enzyme elevations suggest muscle involvement.
  • Mean IQ is in the moderate mental retardation range of 40 to 54, with 25% of tested individuals in the normal range of IQ = 70 or more. Whilst this is by no means "bright" it should be satisfactory for normal schooling. However, more than 80% have maladaptive behaviours, particularly stubbornness, temper tantrums, and stereotypical behaviours that interfere with mainstream education.5 They may seem sociable otherwise. Self injury is not uncommon.
  • Seizures occur in about half and typically appear before 6 years of age. A wide variability in seizure types exists, including myoclonic seizures, generalized tonic-clonic seizures, infantile spasms, and partial complex seizures. The risk of febrile convulsions is 9%, compared with 1% for the general population. See Childhood Epilepsy.
  • Hypophosphataemia, metabolic acidosis, and hypotonia predispose to rickets and osteomalacia. Despite maintenance of normal serum phosphate levels with therapy, osteopenia is a consistent finding. Fractures are common, especially when learning to walk. The femur is often involved.
  • Joint swelling, arthritis, and tenosynovitis are common, especially in the late teens and early adulthood.
  • Scoliosis is common and may progress after puberty. Hypotonia can lead to joint hypermobility. Decreased movements can cause joint contractures.
  • Between 15 and 40% have cryptorchism. Sexual development is normal. Head circumference is normal and final height is low at an average of around 152cm.
Investigations
  • Urine will show excessive loss of bicarbonate, with a pH of 6.0 to 7.5. Aminoaciduria, phosphaturia, calciuria, and proteinuria are present. Water resorption is impaired resulting in high volume and low osmolality. There is hypercalciuria and hyperphosphaturia and L-carnitine is lost in the urine.
  • Hypokalaemia is unusual. Plasma alkaline phosphatase, calcium and phosphorus should be estimated. A rise in alkaline phosphatase is usually the first biochemical indicator of rickets. Carnitine may also be low.
  • Blood gases will show a metabolic acidosis.
  • As the years go by, plasma creatinine will rise and creatinine clearance will fall as chronic renal failure develops.
  • Serum glutamic-oxaloacetic transaminase (SGOT), lactate dehydrogenase (LDH), and creatine kinase (CK) levels often are elevated.
  • There is an elevated concentration of phosphatidylinositol 4,5-bisphosphate, the substrate for the OCRL1 protein and a reproducible cellular abnormality of the actin cytoskeleton in fibroblasts from patients with Lowe's syndrome. There is also an abnormal distribution of gelsolin and alpha-actinin, actin-binding proteins regulated by both phosphatidylinositol 4,5-bisphosphate and calcium that would be expected to be altered in Lowe cells.
  • X-ray of the wrists may show the typical changes of rickets.
  • MRI of the brain may show white matter abnormalities, particularly in the periventricular area. These abnormalities are caused by fluid-filled cysts, which appear to have no clinical significance.
Female carriers

Examination for the carrier state in females has high specificity and sensitivity. In a trial there were 31 females from 3 families, known to be either carriers or not carriers by direct DNA analysis. Slit-lamp biomicroscopy, after dilatation of the pupil, was performed by a single observer who was unaware of the subject's status. Carrier women had small, irregularly-shaped, off-white, nonrefractile, radially arrayed, peripheral cortical lens opacities. No false-positives were found among the 31 females examined. Only one false-negative was found in a girl of 5 years old. They concluded that slit-lamp examination is a highly accurate and sensitive test for carrier detection in Lowe's syndrome, particularly in women of reproductive age.6

Antenatal diagnosis

Because of the allelic heterogeneity of the OCRL gene, prenatal diagnosis by molecular analysis is limited to families in which the mutation is already known or in which linkage is informative. A more generally applicable diagnostic test based on biochemical testing is reported for prenatal diagnosis of Lowe's syndrome by measuring phosphatidylinositol 4,5-bisphosphate 5-phosphatase activity in cultured amniocytes.7

Management

Both surgical and medical interventions are required but there is no cure.

Ophthalmic surgery

  • Early removal of cataracts, even within the first weeks of life, provides the optimal visual stimulation to the developing brain. Lens implantation is not recommended because of growth of the infant eye and because of the propensity to develop glaucoma.
  • Glaucoma develops in about half and is difficult to treat. Surgical implantation of artificial valves to control the release of intraocular fluid is often required.
  • Corneal keloids may require surgical removal of the scar tissue or radiation therapy. Corneal transplantation is difficult because of problems in administering the required intensive postoperative care.
  • Surgical correction of strabismus sometimes is required.

Other surgery

Orchidopexy may be required.

Medical management

  • Management of renal tubular acidosis requires careful monitoring of acid base status and electrolytes. Sodium citrate and citric acid or sodium citrate and potassium citrate are required to maintain plasma bicarbonate levels above 20 mEq/L.
  • Potassium and calcium supplementation may be needed to offset renal losses.
  • Oral carnitine supplementation may be necessary if plasma levels are abnormally low.
  • Neutral phosphate, vitamin D, and careful maintenance of normal acid-base status are necessary to avoid rickets and osteomalacia.

Other interventions

  • There is no clear benefit from special diets.
  • Education will need to be adapted according to needs as dictated by both IQ and behavioural problems.
  • Hypotonia often causes feeding difficulties. Sucking, swallowing, and chewing may be impaired, and therapy may be helpful.
  • Speech and language therapy may be required.
  • Physiotherapy may also be beneficial for the many physical problems.
Prognosis

Slowly progressive renal failure is the major cause of death. Fanconi syndrome of the renal tubule predisposes to dehydration and metabolic imbalance, which can be severe. They have a tendency to develop pneumonia due to hypotonia and poor cough reflex. Other causes of death include infection and status epilepticus, and sudden unexplained death can occur. Death usually occurs in the second or third decade of life.

Genetic counselling

If the proband represents a new mutation the risk to subsequent children is low. If the mother is a carrier there is a 50% chance of any son being affected and any daughter being a carrier.


Document References
  1. OMIM - Lowe syndrome; Lowe syndrome
  2. Loi M; Lowe syndrome.; Orphanet J Rare Dis. 2006 May 18;1(1):16. [abstract]
  3. LOWE CU, TERREY M, MacLACHLAN EA; Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity.; AMA Am J Dis Child. 1952 Feb;83(2):164-84.
  4. Charnas LR, Bernardini I, Rader D, et al; Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function.; N Engl J Med. 1991 May 9;324(19):1318-25. [abstract]
  5. Kenworthy L, Park T, Charnas LR; Cognitive and behavioral profile of the oculocerebrorenal syndrome of Lowe.; Am J Med Genet. 1993 May 15;46(3):297-303. [abstract]
  6. Lin T, Lewis RA, Nussbaum RL; Molecular confirmation of carriers for Lowe syndrome.; Ophthalmology. 1999 Jan;106(1):119-22. [abstract]
  7. Suchy SF, Lin T, Horwitz JA, et al; First report of prenatal biochemical diagnosis of Lowe syndrome.; Prenat Diagn. 1998 Nov;18(11):1117-21. [abstract]

Internet and Further Reading
  • OMIM; - Lowe Syndrome
  • Wasserstein M; Oculocerebrorenal Dystrophy (Lowe Syndrome) eMedicine September 2004
Acknowledgements EMIS is grateful to the Mentor authoring team for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 1013
Document Version: 21
DocRef: bgp1741
Last Updated: 20 Jun 2007
Review Date: 19 Jun 2009






















Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site














Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page